AXA SA (AXAHY) Presents at Bank of America 30th Annual Financials CEO Conference 2025 Transcript

AXA CEO Thomas Buberl highlighted strong performance halfway through their "Unlock the Future" plan, reporting 7% organic growth, 8% underlying EPS growth, and a 220% solvency ratio, with shares at an all-time high. This was driven by a diversified business model, broad-based top-line growth, and strategic margin improvements across P&C, Health, and Life & Savings, which saw positive net flows. The company maintains disciplined capital management, including a EUR 3.8 billion share buyback from the AXA IM sale and targeted investments, while actively managing commercial lines cycles and leveraging acquisitions like Prima to boost direct distribution.

Analysis

AXA is demonstrating strong execution midway through its 'Unlock the Future' plan, evidenced by 7% organic growth, 8% underlying EPS growth, and a robust 220% solvency ratio, which has propelled shares to an all-time high. The CEO attributes this success to a highly diversified business model across geographies and product lines, which provides resilience in a volatile environment. Key strategic initiatives are yielding results: the turnarounds in the U.K. and German Property & Casualty (P&C) businesses are complete, and the company is now focusing on margin improvement in Health and driving growth in Life & Savings. In commercial P&C, management is confident in its ability to navigate a softening cycle by maintaining strict underwriting discipline, focusing on the delta between price increases and claims inflation, and leveraging high barriers to entry in its European SME and AXA XL specialty businesses. The strategic shift in Life & Savings from capital-heavy general accounts to protection and retirement products has successfully reversed net flows to positive territory, positioning it as the next primary growth engine. Furthermore, the acquisition of Prima, a low-cost MGA, is a key strategic move to accelerate the direct distribution channel, combining Prima's innovative pricing model with AXA's scale. This is all underpinned by a disciplined capital management framework, highlighted by a €3.8 billion share buyback following the AXA IM disposal.

Key Decisions for Investors

• Investors should recognize a clear validation of the current strategy, as demonstrated by strong execution, a 220% solvency ratio, and a disciplined capital return policy that includes a 60% dividend payout and a €3.8 billion share buyback.
• The strategic pivot in Life & Savings, which has already turned net flows positive, represents the next significant growth driver, and progress in scaling the Prima acquisition should be monitored as a key catalyst for the direct channel.
• While management is confident, it is prudent to monitor the AXA XL division's margins to validate the effectiveness of its cycle management, particularly the spread between pricing and claims inflation in softening lines like U.S. professional and cyber.
• The CEO's commentary suggests a growth runway extending beyond the current plan, with Life & Savings and Health set to become the next chapters, warranting a long-term view on the company's value creation potential.